Book value compounding
Net worth compounded at 26.8% a year over 4 years (₹11,769 → ₹30,458).
Importance 62 / 95 · financial health
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Net worth compounded at 26.8% a year over 4 years (₹11,769 → ₹30,458).
Importance 62 / 95 · financial health
Revenue compounded at 32.3% a year over 4 years (₹10,141 → ₹31,073) — though FY2024 saw a one-off step-change of 49% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Importance 52 / 95 · growth
Over 4 years profit compounded at 24.9% a year while the stock returned 9.1% a year — the FY2022 base was somewhat depressed, so part of this is recovery rather than trend.
Importance 51 / 95 · business vs stock
Classified by the exchange under Financial Services › Financial Services › Finance › Non Banking Financial Company (NBFC).
Peer set used on this page: 5 non banking financial company (nbfc).
Revenue compounded at 32.3% a year over 4 years (₹10,141 → ₹31,073) — though FY2024 saw a one-off step-change of 49% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Rule REVENUE_CAGR_STRONG
Net profit grew 22.8% year on year (FY2025 → FY2026).
Revenue grew 20.2% year on year (FY2025 → FY2026).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q1 FY27 net profit was ₹1,656 cr, up 45.6% from ₹1,138 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q1 FY27 revenue was ₹8,856 cr, up 21.9% from ₹7,267 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q1 FY27 EBIT was ₹6,229 cr, up 24.6% from ₹4,999 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY25 | 6,255 | — | 968 | — | 15.5% |
| Q3 FY25 | 6,733 | +34.5% | 1,088 | +24.8% | 16.2% |
| Q4 FY25 | 7,046 | +29.8% | 1,260 | +18.2% | 17.9% |
| Q1 FY26 | 7,267 | +25.0% | 1,138 | +20.1% | 15.7% |
| Q2 FY26 | 7,491 | +19.8% | 1,160 | +19.8% | 15.5% |
| Q3 FY26 | 7,898 | +17.3% | 1,290 | +18.5% | 16.3% |
| Q4 FY26 | 8,417 | +19.5% | 1,645 | +30.6% | 19.5% |
| Q1 FY27 | 8,856 | +21.9% | 1,656 | +45.6% | 18.7% |
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
Margin and return trends are shown above.
Net worth compounded at 26.8% a year over 4 years (₹11,769 → ₹30,458).
Rule NET_WORTH_COMPOUNDING
Ranked against 5 non banking financial company (nbfc) (FY2026, consolidated). No peer-relative rule fired for this company.
CHOLAFIN · 2nd of 4 · set median 18.9%
CHOLAFIN · 4th of 5 · set median 73.3%
CHOLAFIN · 2nd of 5 · set median 17.9%
CHOLAFIN · 3rd of 5 · set median 23.5×
On the trailing twelve months. Last full year: P/E 25.8× · P/S 4.3× · ROE 19.3%.
Over 4 years profit compounded at 24.9% a year while the stock returned 9.1% a year — the FY2022 base was somewhat depressed, so part of this is recovery rather than trend.
Rule STOCK_LAGGED_EARNINGS · rebound
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 10,048 | 12,757 | 18,845 | 25,746 | 30,982 |
| Total income | 10,139 | 12,978 | 19,216 | 26,055 | 31,445 |
| EBITDA | 7,287 | 9,467 | 14,008 | 18,464 | 21,616 |
| Profit before tax | 2,891 | 3,600 | 4,582 | 5,737 | 6,961 |
| Net profit | 2,147 | 2,666 | 3,423 | 4,259 | 5,220 |
| EPS (₹) | 26.2 | 32.5 | 41.2 | 50.7 | 61.8 |
| Net worth | 11,708 | 14,296 | 19,557 | 23,627 | 30,404 |
| Operating cash flow | −5,608 | −27,037 | −35,768 | −32,404 | −29,920 |
| Free cash flow | −5,662 | −27,174 | −36,811 | −32,586 | −30,161 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | 27.0 | 47.7 | 36.6 | 20.3 |
| Profit growth YoY | — | 24.2 | 28.4 | 24.4 | 22.6 |
| Profitability | |||||
| EBITDA margin % | 72.5 | 74.2 | 74.3 | 71.7 | 69.8 |
| Net margin % | 21.2 | 20.5 | 17.8 | 16.3 | 16.6 |
| Return on equity % | 18.3 | 20.5 | 20.2 | 19.7 | 19.3 |
| Return on capital % | — | — | — | — | — |
| Leverage & cash | |||||
| Debt to equity | — | — | — | — | — |
| Cash flow ÷ profit | -2.61 | -10.14 | -10.45 | -7.61 | -5.73 |
| Current ratio | — | — | — | — | — |